Received Jun 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ANTH | ANTHRAX (BIOTHRAX) | EMERGENT BIOSOLUTIONS | 3 | 300217A | IM / RA |
3 days post vaccination, patient reported greater than normal swelling/irritation at injection site. Noticed yellow/purple discoloration in a ~3-inch diameter around injection site with pain, redness and swelling also present in same area.
None known
Recent hip surgery (~2months)
Multivitamin, vitamin D
NKA
No tests conducted. Only physical exam and patient given antibiotics at the ER.